Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Dente, Federico L ^a   Bilotta, Marta ^a   Bartoli, Maria Laura ^a   Bacci, Elena ^a   Cianchetti, Silvana ^a   Latorre, Manuela ^a   Malagrinò, Laura ^a   Nieri, Dario ^a   Roggi, Maria Adelaide ^a   Vagaggini, Barbara ^a   Paggiaro, Pierluigi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MALONALDEHYDE; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BRONCHIECTASIS; BRONCHITIS; CARDIOVASCULAR DISEASE; COMORBIDITY; COUGHING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL DISEASE; HEMOPTYSIS; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHILIA; NEUTROPHILIC BRONCHIAL INFLAMMATION; NONCYSTIC FIBROSIS BRONCHIECTASIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SPUTUM ANALYSIS; UPPER RESPIRATORY TRACT INFECTION; AGED; BREATH ANALYSIS; BRONCHUS; CYTOLOGY; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SPUTUM;

ADULT; AGED; BREATH TESTS; BRONCHI; BRONCHIECTASIS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 84956895035     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/642503     Document Type: Article

References (30)

1. A. T. Hill, M. Pasteur, C. Cornford, S. Welham, and D. Bilton, "Primary care summary of the British thoracic society guideline on the management of non-cystic fibrosis bronchiectasis, " Primary Care Respiratory Journal, vol. 20, no. 2, pp. 135-140, 2011.
2. M. Gaga, A. M. Bentley, M. Humbert et al., "Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis, " Thorax, vol. 53, no. 8, pp. 685-691, 1998.
3. P. T. King, "The pathophysiology of bronchiectasis, " International Journal of ChronicObstructive PulmonaryDisease, vol. 4, pp. 411-419, 2009.
4. J. D. Chalmers, M. P. Smith, B. J. McHugh, C. Doherty, J. R. Govan, and A. T. Hill, "Short-and long-term antibiotic treatment reduces airway and systemic inflammation in noncystic fibrosis bronchiectasis, " American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 7, pp. 657-665, 2012.
5. T. Guran, R. Ersu, B. Karadag et al., "Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis, " Pediatric Pulmonology, vol. 42, no. 4, pp. 362-369, 2007.
6. P. C. Goeminne, J. Vandooren, E. A. Moelants et al., "The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis, " Respirology, vol. 19, no. 2, pp. 203-210, 2014.
7. S. L. Taylor, G. B. Rogers, A. C. Chen, L. D. Burr, M. A. McGuckin, and D. J. Serisier, "Matrix metalloproteinases vary with airway microbiota composition and lung function in noncystic fibrosis bronchiectasis, " Annals of the American Thoracic Society, vol. 12, no. 5, pp. 701-707, 2015.
8. S. Loukides, D. Bouros, G. Papatheodorou, S. Lachanis, P. Panagou, and N. M. Siafakas, "Exhaled H2O2 in steadystate bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease, " Chest, vol. 121, no. 1, pp. 81-87, 2002.
9. W. R. Webb, N. L. Muller, and D. P. Naidich, High-Resolution CT of the Lung, chapter 8, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 3rd edition, 2001.
10. M. C. Pasteur, D. Bilton, A. T. Hill, and BritishThoracic Society Bronchiectasis non-CF Guideline Group, "British Thoracic Society guideline for non-CF bronchiectasis, " Thorax, vol. 65, supplement 1, pp. i1-i58, 2010.
11. M. P. Murray, K. Turnbull, S. MacQuarrie, J. L. Pentland, and A. T. Hill, "Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis, " European Respiratory Journal, vol. 34, no. 1, pp. 125-131, 2009.
12. J. Bonavita and D. P. Naidich, "Imaging of bronchiectasis, " Clinics in Chest Medicine, vol. 33, no. 2, pp. 233-248, 2012.
13. M. A. Martínez-Garća, J. de Gracia, M. V. Relat et al., "Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score, " European Respiratory Journal, vol. 43, no. 5, pp. 1357-1367, 2014.
14. J. D. Chalmers, P. Goeminne, S. Aliberti et al., "The bronchiectasis severity index. An international derivation and validation study, " American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 5, pp. 576-585, 2014.
15. M. R. Miller, J. Hankinson, V. Brusasco et al., "Standardization of spirometry, " European Respiratory Journal, vol. 26, no. 2, pp. 319-338, 2005.
16. P. L. Paggiaro, P. Chanez, O. Holz et al., "Sputum induction, " The European Respiratory Journal. Supplement, vol. 37, pp. 3s-8s, 2002.
17. B. Vagaggini, M. L. E. Bartoli, S. Cianchetti et al., "Increase in markers of airway inflammation after ozone exposure can be observed also in stable treated asthmatics with minimal functional response to ozone, " Respiratory Research, vol. 11, article 5, 2010.
18. E. Bacci, S. Cianchetti, S. Carnevali et al., "Induced sputum is a reproducible method to assess airway inflammation in asthma, " Mediators of Inflammation, vol. 11, no. 5, pp. 293-298, 2002.
19. I. Horváth, J. Hunt, P. J. Barnes et al., "Exhaled breath condensate: methodological recommendations and unresolved questions, " European Respiratory Journal, vol. 26, no. 3, pp. 523-548, 2005.
20. M. Lärstad, G. Ljungkvist, A.-C. Olin, and K. Toŕen, "Determination of malondialdehyde in breath condensate by highperformance liquid chromatography with fluorescence detection, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 766, no. 1, pp. 107-114, 2002.
21. M. L. Bartoli, F. Novelli, F. Costa et al., "Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases, " Mediators of Inflammation, vol. 2011, Article ID 891752, 7 pages, 2011.
22. American Thoracic Society, "Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999, " American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 2104-2117, 1999.
23. J. Belda, R. Leigh, K. Parameswaran, P. M. OByrne, M. R. Sears, and F. E. Hargreave, "Induced sputum cell counts in healthy adults, " American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2, part 1, pp. 475-478, 2000.
24. G. B. Rogers, C. J. van der Gast, L. Cuthbertson et al., "Clinical measures of disease in adult non-CF bronchiectasis correlate with airwaymicrobiota composition, " Thorax, vol. 68, no. 8, pp. 731-737, 2013.
25. M. Luján, X. Gallardo, M. J. Amengual, M. Bosque, R. M. Mirapeix, and C. Domingo, "Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels, " BioMed Research International, vol. 2013, Article ID 109219, 7 pages, 2013.
26. S. Fuschillo, A. De Felice, and G. Balzano, "Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms, " European Respiratory Journal, vol. 31, no. 2, pp. 396-406, 2008.
27. I. Rahman, "The role of oxidative stress in the pathogenesis of COPD: implications for therapy, " Treatments in Respiratory Medicine, vol. 4, no. 3, pp. 175-200, 2005.
28. A. Ahmad, M. Shameem, and Q. Husain, "Relation of oxidantantioxidant imbalance with disease progression in patients with asthma, " Annals ofThoracic Medicine, vol. 7, no. 4, pp. 226-232, 2012.
29. A. D. Diego, J. Milara, E. Martinez-Moragón, M. Palop, M. Léon, and J. Cortijo, "Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis, " Respirology, vol. 18, no. 7, pp. 1056-1062, 2013.
30. A. Bhowmik, T. A. R. Seemungal, R. J. Sapsford, J. L. Devalia, and J. A. Wedzicha, "Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease, " Thorax, vol. 53, no. 11, pp. 953-956, 1998.